Maiques O, Sallan M, Laddach R, Pandya P, Varela A, Crosas-Molist E
Nat Commun. 2025; 16(1):1394.
PMID: 39952917
PMC: 11829002.
DOI: 10.1038/s41467-025-56299-7.
Zamay T, Zamay S, Zamay G, Kolovskaya O, Kichkailo A, Berezovski M
Cancers (Basel). 2025; 17(2).
PMID: 39858068
PMC: 11764231.
DOI: 10.3390/cancers17020286.
Zhou S, Zhao Z, Wang Z, Xu H, Li Y, Xu K
J Transl Med. 2025; 23(1):50.
PMID: 39806363
PMC: 11727299.
DOI: 10.1186/s12967-025-06071-8.
Fouillet J, Torchio J, Rubira L, Fersing C
Biology (Basel). 2025; 13(12.
PMID: 39765634
PMC: 11673949.
DOI: 10.3390/biology13120967.
Alqabandi J, David R, Abdel-Motal U, ElAbd R, Youcef-Toumi K
Sci Rep. 2024; 14(1):30107.
PMID: 39627312
PMC: 11615046.
DOI: 10.1038/s41598-024-79154-z.
The axis of tumor-associated macrophages, extracellular matrix proteins, and cancer-associated fibroblasts in oncogenesis.
Yu S, Wang S, Wang X, Xu X
Cancer Cell Int. 2024; 24(1):335.
PMID: 39375726
PMC: 11459962.
DOI: 10.1186/s12935-024-03518-8.
Cell blebbing novel therapeutic possibilities to counter metastasis.
Jia W, Czabanka M, Broggini T
Clin Exp Metastasis. 2024; 41(6):817-828.
PMID: 39222238
PMC: 11607095.
DOI: 10.1007/s10585-024-10308-z.
Enhanced RHO-ROCK signaling is associated with CRELD2 production and fibroblast recruitment in cutaneous squamous cell carcinoma.
Pittar A, Buckley E, Boyle S, Ibbetson S, Samuel M
Cytoskeleton (Hoboken). 2024; 81(12):864-871.
PMID: 38979935
PMC: 11615837.
DOI: 10.1002/cm.21894.
Proteolysis-free amoeboid migration of melanoma cells through crowded environments via bleb-driven worrying.
Driscoll M, Welf E, Weems A, Sapoznik E, Zhou F, Murali V
Dev Cell. 2024; 59(18):2414-2428.e8.
PMID: 38870943
PMC: 11421976.
DOI: 10.1016/j.devcel.2024.05.024.
Alarmin S100A8 imparts chemoresistance of esophageal cancer by reprogramming cancer-associated fibroblasts.
Chen X, Cheng G, Zhu L, Liu T, Yang X, Liu R
Cell Rep Med. 2024; 5(6):101576.
PMID: 38776909
PMC: 11228400.
DOI: 10.1016/j.xcrm.2024.101576.
Tumor associated macrophages as key contributors and targets in current and future therapies for melanoma.
Habib S, Osborn G, Willsmore Z, Chew M, Jakubow S, Fitzpatrick A
Expert Rev Clin Immunol. 2024; 20(8):895-911.
PMID: 38533720
PMC: 11286214.
DOI: 10.1080/1744666X.2024.2326626.
Recent advances in cancer-associated fibroblast: Biomarkers, signaling pathways, and therapeutic opportunities.
Zhou D, Zheng L
Chin Med J (Engl). 2024; 137(6):638-650.
PMID: 38420743
PMC: 10950138.
DOI: 10.1097/CM9.0000000000003031.
Cancer-Associated Fibroblast Heterogeneity in Malignancy with Focus on Oral Squamous Cell Carcinoma.
Arebro J, Lee C, Bennewith K, Garnis C
Int J Mol Sci. 2024; 25(2).
PMID: 38279300
PMC: 10816981.
DOI: 10.3390/ijms25021300.
Development of a cancer metastasis-on-chip assay for high throughput drug screening.
Ozer L, Fayed H, Ericsson J, Al Haj Zen A
Front Oncol. 2024; 13:1269376.
PMID: 38239643
PMC: 10794518.
DOI: 10.3389/fonc.2023.1269376.
Role of autophagy in cancer-associated fibroblast activation, signaling and metabolic reprograming.
Sari D, Gozuacik D, Akkoc Y
Front Cell Dev Biol. 2024; 11:1274682.
PMID: 38234683
PMC: 10791779.
DOI: 10.3389/fcell.2023.1274682.
Roles and signaling pathways of CITED1 in tumors: overview and novel insights.
Chen W, Jiang J, Gao J, Wang G, Wang R, Lv J
J Int Med Res. 2024; 52(1):3000605231220890.
PMID: 38190845
PMC: 10775745.
DOI: 10.1177/03000605231220890.
Down-regulation of COL1A1 inhibits tumor-associated fibroblast activation and mediates matrix remodeling in the tumor microenvironment of breast cancer.
Ma B, Li F, Ma B
Open Life Sci. 2023; 18(1):20220776.
PMID: 38045487
PMC: 10693014.
DOI: 10.1515/biol-2022-0776.
, a Natural Antisense Transcript of , Promotes Tumour Progression and Metastasis in Melanoma.
Dutriaux A, Diazzi S, Bresesti C, Hardouin S, Deshayes F, Collignon J
Noncoding RNA. 2023; 9(6).
PMID: 37987367
PMC: 10661258.
DOI: 10.3390/ncrna9060071.
CD73 controls Myosin II-driven invasion, metastasis, and immunosuppression in amoeboid pancreatic cancer cells.
Samain R, Maiques O, Monger J, Lam H, Candido J, George S
Sci Adv. 2023; 9(42):eadi0244.
PMID: 37851808
PMC: 10584351.
DOI: 10.1126/sciadv.adi0244.
The activation of INF2 by Piezo1/Ca is required for mesenchymal to amoeboid transition in confined environments.
Kar N, Caruso A, Prokopiou N, Logue J
bioRxiv. 2023; .
PMID: 37745412
PMC: 10515767.
DOI: 10.1101/2023.06.23.546346.